Skip to Main Content
Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Diabetes and COVID-19 Articles

Diabetes and COVID-19 Articles
Complications
Impacts of COVID-19 on Glycemia and Risk of Diabetic Ketoacidosis
September 15 2023
https://doi.org/10.2337/db22-0264
Genetics/Genomes/Proteomics/Metabolomics
Causal Associations Between Basal Metabolic Rate and COVID-19
October 10 2022
https://doi.org/10.2337/db22-0610
Pathophysiology
Incidence Trends of New-Onset Diabetes in Children and Adolescents Before and During the COVID-19 Pandemic: Findings From Florida
September 12 2022
https://doi.org/10.2337/db22-0549
Diabetes and COVID19 Articles
Immunogenicity and Safety of SARS-CoV-2 mRNA Vaccines in a Cohort of Patients With Type 1 Diabetes
August 21 2022
https://doi.org/10.2337/db22-0053
Diabetes and COVID19 Articles
Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets
May 02 2022
https://doi.org/10.2337/db21-0926
Pathophysiology
Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2–Infected Young Individuals: Is It Type 1 Diabetes?
March 16 2022
https://doi.org/10.2337/db21-0831
Complications
Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19
January 21 2022
https://doi.org/10.2337/db21-0965
Perspectives in Diabetes
COVID-19–Induced New-Onset Diabetes: Trends and Technologies
October 22 2021
https://doi.org/10.2337/dbi21-0029
Perspectives in Diabetes
Possible Involvement of Adipose Tissue in Patients With Older Age, Obesity, and Diabetes With SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19
October 22 2021
https://doi.org/10.2337/db20-1094
Complications
Diabetes and the Risk of Long-term Post-COVID Symptoms
September 27 2021
https://doi.org/10.2337/db21-0329
Complications
Diabetes, Drug Treatment, and Mortality in COVID-19: A Multinational Retrospective Cohort Study
September 27 2021
https://doi.org/10.2337/db21-0385
Complications
LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes
June 15 2021
https://doi.org/10.2337/db20-1260
Perspectives in Diabetes
How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?
February 25 2021
https://doi.org/10.2337/dbi20-0045
Obesity Studies
Obesity and COVID-19 in Adult Patients With Diabetes
February 17 2021
https://doi.org/10.2337/db20-0671
Complications
Lung and Kidney ACE2 and TMPRSS2 in Renin-Angiotensin System Blocker–Treated Comorbid Diabetic Mice Mimicking Host Factors That Have Been Linked to Severe COVID-19
December 11 2020
https://doi.org/10.2337/db20-0765
Pathophysiology
Expression of ACE2, the SARS-CoV-2 Receptor, in Lung Tissue of Patients With Type 2 Diabetes
October 06 2020
https://doi.org/10.2337/db20-0669
Perspectives in Diabetes
COVID-19 and Diabetes: A Collision and Collusion of Two Diseases
September 16 2020
https://doi.org/10.2337/dbi20-0032
Perspectives in Diabetes
Managing Hyperglycemia in the COVID-19 Inflammatory Storm
August 10 2020
https://doi.org/10.2337/dbi20-0022
Perspectives in Diabetes
Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19
July 15 2020
https://doi.org/10.2337/dbi19-0023
Perspectives in Diabetes
SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes
July 15 2020
https://doi.org/10.2337/dbi20-0019

Journals

Books

Clinical Compendia

News

Other

About

Resources

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept